We are live on
!
Find out more
TI
Truehand Inc Portfolio holdings
AUM
$171M
1-Year Est. Return
25.9%
This Fund
S&P 500
This Quarter
Est. Return
+4.8%
1 Year Est. Return
+25.9%
3 Year Est. Return
+86.86%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$170M
AUM Growth
+$6.05M
(+3.7%)
Cap. Flow
-$373K
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
37.45%
Holding
202
New
2
Increased
–
Reduced
3
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$107K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$212K |
| 2 |
HP
HPQ
|
+$122K |
| 3 |
Merck
MRK
|
+$116K |
| 4 |
Amazon
AMZN
|
+$16.6K |
| 5 |
Nucor
NUE
|
+$11.7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23.2% |
| 2 | Consumer Staples | 14.57% |
| 3 | Healthcare | 14.4% |
| 4 | Industrials | 12.29% |
| 5 | Real Estate | 7.41% |
Similar funds
KM
GC
MC
REMS
NM
FAC
ACM
MSO
Truehand Inc's Q2 2021 Portfolio in Review
As of Q2 2021, Truehand Inc held 202 positions worth $170M, up 3.7% from $164M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 2.5%. Truehand Inc opened 2 new positions and exited 3, leaving the 202-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, down from 24% a quarter earlier, followed by Consumer Staples and Healthcare.
- Truehand Inc's largest Q2 2021 buy was Organon & Co: 3,257 shares worth $99K.
- Truehand Inc's biggest Q2 2021 reduction was Merck, cutting an estimated $116K.
- Truehand Inc fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $212K.
- Truehand Inc's ten largest holdings make up 37% of its $170M portfolio in Q2 2021.
- Truehand Inc opened 2 new positions and closed 3 in Q2 2021.
- Truehand Inc's portfolio value rose 3.7% quarter-over-quarter to $170M.
Based on Truehand Inc's 13F filing for Q2 2021, filed 7 Jul 2021.